Related Experiment Video
Updated: Oct 13, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.4K
COVID-19-Induced Cavitary Lesion: A Rare Presentation
Steven Douedi1, Sydney Kauffman2, Mohammed AlAzzawi1
1Internal Medicine, Jersey Shore University Medical Center, Neptune, USA.
Cureus
|November 18, 2021
Summary
This study reports a rare case of cavitary lesions in a patient recovering from coronavirus disease 2019 (COVID-19). The patient improved with supportive care, highlighting the need for further research on managing these COVID-19 complications.
Area of Science:
- Pulmonology
- Infectious Diseases
- Radiology
Background:
- The COVID-19 pandemic has caused significant global morbidity and mortality.
- While primarily affecting the respiratory system, COVID-19 can manifest with systemic complications.
- Cavitary lesions are a rare, poorly understood manifestation of COVID-19.
Observation:
- A case study involving a patient with a history of COVID-19 infection.
- The patient presented with newly developed cavitary lesions.
- These lesions were monitored and managed conservatively.
Findings:
- The patient's cavitary lesions showed improvement with supportive care alone.
- This suggests a potential self-limiting or manageable course for some COVID-19-associated cavitary lesions.
- The exact pathophysiology and optimal treatment remain unclear.
Implications:
- This case contributes to the limited literature on COVID-19-related cavitary lesions.
- Supportive care may be a viable initial management strategy.
- Further extensive studies are required to establish definitive clinical guidelines for managing these rare pulmonary findings in COVID-19 patients.
Related Concept Videos
01:28Pulmonary Tuberculosis V
264
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
264
01:20COPD: Pathogenesis and Clinical Features
682
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
682
01:21Barrett Esophagus-II: Clinical Manifestations and Management
340
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
340
01:28Esophageal Perforation-II: Clinical Manifestations and Management
173
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
173
01:23Cystic Fibrosis: Pathogenesis
399
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
399
01:25Pleural Effusion I: Introduction
2.3K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
2.3K